Autres langues BriaCell Therapeutics Corp.

Actions

BCT

CA1079301091

Marché Fermé - Toronto S.E. Autres places de cotation 20:26:51 08/05/2024			Varia. 5j.	Varia. 1 janv.
3,08 ^CAD	+0,33%		+6,57%	-60,51%

10/04	BriaCell 2024 L'affiche préclinique de l'AACR confirme la forte activité anticancéreuse des candidats cliniques Bria-OTS+ ? et Bria-PROS+ ? candidats cliniques pour le cancer du sein et de la prostate	CI
09/04	BriaCell présentera les dernières données de Bria-IMT dans des présentations d'affiches à 2024 AACR	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

BriaCell Therapeutics to Present Bria-IMT Phase 2 Findings at American Society of Clinical Oncology Annual Meeting	24/04
BriaCell Announces Oral and Poster Presentations at ASCO 2024	24/04
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+™ and Bria-PROS+™ Clinical Candidates for Breast and Prostate Cancer	10/04
BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+? and Bria-PROS+? Clinical Candidates for Breast and Prostate Cancer	10/04
BriaCell to Showcase Latest Bria-IMT Data in Poster Presentations at 2024 AACR	09/04
BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR	09/04
BriaCell Therapeutics : NOTICE OF NO AUDITOR REVIEW OF THE CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS - Form 8-K	02/04
BriaCell Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	18/03
BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies	07/03
BriaCell to Present Clinical Data in CNS Metastasis and Antibody-Drug Conjugate Resistant Breast Cancer at AACR Conference	06/03
BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference	06/03
BriaCell Provides Update on Alleged Illegal Trading of Public Securities	27/02
BriaCell Announces Strong Clinical Data in Breast Cancer Patients	07/02
BriaCell Therapeutics Corp. Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	07/02
BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case	07/02
Toronto Stocks Rally; Precision Drilling Rises on 4Q Profit Growth	06/02
Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing	06/02
Briacell Therapeutics Corp. Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates Gmp Manufacturing	06/02
BriaCell Therapeutics Corp. Announces Results of Shareholder Meeting	31/01
BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast Cancer	04/01

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues BriaCell Therapeutics Corp.

Actions

BCT

CA1079301091

Autres langues

Filtres